| Literature DB >> 7761070 |
Z Sándor1, S Kusstatscher, D Szeli, S Szabó.
Abstract
The role of Platelet-Derived Growth Factor (PDGF) was investigated in treatment of experimental inflammatory bowel disease (IBD) in animal models. A new model of IBD induced by the sulfhydryl (SH) alkylator iodoacetamide revealed that the most appropriate concentration of iodoacetamide is 6% given intracolonically once. Daily treatment with PDGF dose-dependently accelerated the healing of colonic erosions, ulcers and inflammation.Entities:
Mesh：
Substances：
Year: 1995 PMID： 7761070
Source DB: PubMed Journal: Orv Hetil ISSN： 0030-6002 Impact factor: 0.540